CD8A and neoplasm: An initial comprehensive analysis of CD8+ TRM cells, as another subset of TILs, in PTC samples, revealed a lower proportion of this population in the more advanced stage of disease, consistent with an anti-tumor phenotype [112,113], but further work is required to better understand their prognostic value.